Tuesday, November 24, 2009, 4:45am EST - Canadian Markets open in 4 hours and 45 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

BioSpecifics Technologies Corp. (BSTC.OB)

 On Nov 17: 16.00 USD   0.00 (0.00%)  
MORE ON BSTC.OB
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
BIOSPECIFICS TECH CP (OTC BB:BSTC.OB) Delayed quote dataEdit
Last Trade: 16.00 USD
Trade Time: Nov 17
Change: 0.00 (0.00%)
Prev Close: 16.00
Open: N/A
Bid: N/A
Ask: N/A
1y Target Est: N/A
Day's Range: N/A - N/A
52wk Range: 10.50 - 33.00
Volume: 0
Avg Vol (3m): 17,392.3
Market Cap: N/A
P/E (ttm): N/A
EPS (ttm): -0.56
Div & Yield: N/A (N/A%)
BioSpecifics Technologies Corp. (BSTC.OB)
1d  5d  3m  6m  1y  2y  5y  max 
 Add BSTC.OB to Portfolio   Download Data

HEADLINES
• BIOSPECIFICS TECHNOLOGIES CORP Financials
EDGAR Online Financials (Sat, Aug 22)
• BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Aug 13)
• BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 10-Q, Quarterly Report
EDGAR Online (Thu, Aug 13)
• BIOSPECIFICS TECHNOLOGIES CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statement
EDGAR Online (Wed, Aug 12)
• BioSpecifics Technologies Corp. Reports Second Quarter 2009 Financial Results
PRNewswire (Wed, Aug 12)
• Q2 2009 Biospecifics Technologies Earnings Release - Time Not Supplied
CCBN (Wed, Aug 12)
• BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
PRNewswire (Tue, Aug 4)
• BioSpecifics Technologies Corp. to Present at CapStone Investments' Third Annual Small-Cap Investor Conference
PRNewswire (Wed, Jul 22)
• BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes
PRNewswire (Mon, Jun 29)
• Coverage initiated on BioSpecifics Tech. Corp by Hapoalim
Briefing.com (Mon, Jun 15)
More Headlines for BSTC.OB...
BUSINESS SUMMARY
BioSpecifics Technologies Corp., a biopharmaceutical company, involves in the development of injectable collagenase for multiple indications. It has a development and license agreement with Auxilium Pharmaceuticals, Inc. for injectable collagenase...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices